News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
Format:Category:
1 Results– filtered by:#RNhale
Interviews
Rnhale: Inhalable RNA for new therapies
The Munich-based biotech startup Rnhale develops inhalable RNA therapeutics as dry powder – faster, simpler, and more efficient than previous approaches. This is intended to treat respiratory diseases such as COPD or asthma in a targeted manner. CEO Benjamin Winkeljann explains in an interview why the path from research to product is challenging and what hurdles almost caused them to fail.
23.03.26
4 Min.